“Zanubrutinib as upfront treatment in de-novo B-cell prolymphocytic leukemia: the case of two elderlies”. (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025061. doi:10.4084/MJHID.2025.061.